Lv45
490 积分 2022-01-11 加入
Targeting CDK12/13 Drives Mitotic Arrest to Overcome Resistance to KRASG12C Inhibitors
7天前
已完结
RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wildtype RAS Activation in Non-Small Cell Lung Cancer
7天前
已完结
Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non–Small Cell Lung Cancer
8天前
已完结
The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies
8天前
已完结
EGFR -Mutated Lung Cancer — Letting the Butterfly Out of the Cocoon
8天前
已完结
The Story of EGFR: From Signaling Pathways to a Potent Anticancer Target
14天前
已完结
Unlocking RAS: Finding the Right Combination Is the Key
16天前
已完结
Structural basis of T-loop–independent recognition and activation of CDKs by the CDK-activating kinase
17天前
已完结
The molecular aspects in prostatic cancer, unraveling the role of CDKs in prostate cancer progression
22天前
已完结
Targeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
27天前
已完结
皖公网安备34019202002308
